Composition

Each 3 mL vial contains: Cabotegravir 600 mg Excipients q.s.  

ATC Code

J05AJ04  

Product Category

Drugs

Marketing Category

Prescription-only Medicine (POM)  

Packsize

1 x 1 vial, 1 x 25 vials  

Product Description

Suspension for Injection 31 NF-PP-335639 Apretude 600 mg Prolonged-release Suspension for Injection Cabotegravir Cabotegravir 600 mg, Mannitol (E421) Polysorbate 20 (E432) Macrogol (E1521) Water for injections Drugs Imported Products 1vial,1vial*25 Prescription Only Medicine (POM) 6/22/2023 GLAXOSMITHKLINE PHARMACEUTICAL NIGERIA LTD., INDUSTRIAL AVENUE ILUPEJU LAGOS 12711000 regulatorypharma-ng@gsk.com Glaxo Operations UK Limited (trading as Glaxo Wellcome Operations) , Harmire Road Barnard Castle Co. Durham DL12 8DT United Kingdom, United Kingdom

Manufacturer Name

Glaxo Operations UK Limited

Manufacturer Country

UNITED KINGDOM  

Approval Date

2023-09-28  

Expiry Date

2028-09-27